ZIXI - Zix Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
6.63
+0.06 (+0.91%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close6.57
Open6.57
Bid6.62 x 1200
Ask6.95 x 1300
Day's Range6.55 - 6.70
52 Week Range5.25 - 11.15
Volume281,779
Avg. Volume570,680
Market Cap370M
Beta (5Y Monthly)0.97
PE Ratio (TTM)N/A
EPS (TTM)-0.20
Earnings DateFeb 26, 2020 - Mar 2, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date1996-09-11
1y Target Est11.80
  • Hedge Funds Are Buying Zix Corporation (ZIXI)
    Insider Monkey

    Hedge Funds Are Buying Zix Corporation (ZIXI)

    Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved dearly, lost nearly 40% of its value at one point in 2018. Although hedge funds are not perfect, their consensus picks do deliver solid returns, however. Our data show the top 20 S&P 500 […]

  • Business Wire

    Zix-AppRiver Survey: Small Businesses Believe They Will Be Targets of Cyberattacks by Foreign Adversaries in 2020

    AppRiver, a Zix (ZIXI) company and leading channel-first provider of security, productivity and compliance solutions, today announced the findings of its Q4 Cyberthreat Index for Business Survey, uncovering the top cybersecurity concerns and mitigation strategies among small- and medium-sized businesses (SMBs) as they move into 2020. With cybersecurity concerns already mounting ahead of the 2020 presidential election, SMB executives are turning their attention to how these threats could impact their own business. “In 2019, we saw cyberattacks on our government trickle down from large agencies to smaller local municipalities and schools,” said Dave Wagner, CEO, Zix.

  • Business Wire

    Zix Sets December 2019 Financial Conference Schedule

    Zix Corporation , a leading provider of cloud email security solutions, is scheduled to participate at the following financial conferences during December 2019:

  • Is There Now An Opportunity In Zix Corporation (NASDAQ:ZIXI)?
    Simply Wall St.

    Is There Now An Opportunity In Zix Corporation (NASDAQ:ZIXI)?

    Zix Corporation (NASDAQ:ZIXI), which is in the software business, and is based in United States, saw a decent share...

  • 3 Stocks That Wall Street Thinks Could Rise 40% or More
    TipRanks

    3 Stocks That Wall Street Thinks Could Rise 40% or More

    After a period of uncertainty, confidence has returned to the market and sent stock prices soaring. This raises the question, have stocks soared too high?Not according to Goldman Sachs’ Silvia Ardagna. The economist believes that while the global economy might be slowing down, the US economy is stronger than most other regions and there is yet more fuel left in the tank to propel it forward.“The de-escalation of trade tensions between the U.S. and China has triggered the question whether investors have been too negative and there could be some positive surprises,” said Ardagna, adding, “The main returns in our view still come from having an overweight to U.S. equities.”There’s no one true strategy to guarantee making money in the investment markets, but finding a stock a with strong upside potential is a good beginning. Today, we’ve used TipRanks’ Stock Screener to find three Strong Buys with buy-side potential over 40%. They come from a range of sectors – education, biopharmaceuticals, technology – and only two are showing positive performance so far this year. But all have attracted serious attention from high-rated analysts, who have seen clear paths toward high profitability for each of them.Aspen Group (ASPU)Starting in the education-tech field, Aspen Group operates two private, for-profit universities, the United States University based in San Diego and the distance-learning Aspen University. Both are accredited colleges and offer a variety of undergrad and post-graduate courses and programs.Education is an in-demand field, and Aspen’s Q1 fiscal 2020 earnings reflect that demand. Student enrollment was up 46% year-over-year, with 1,929 new enrollments, and revenues were up 43% to $10.4 million – a record for the company. CEO Michael Matthews noted a key point in the earnings: “Fiscal 2020 is off to a strong start with record revenue and enrollments in our seasonally weakest summer quarter.”After difficult stock performance through the summer, ASPU shares took off at the end of August, and the stock is up 21.5% year-to-date.Northland analyst Michael Grondahl notes an important point that is easily overlooked: Both of Aspen’s universities offer degrees and accreditation programs in nursing, a field in high demand. In his initiation-of-coverage report, Grondahl says of ASPU generally, “We believe Aspen Group represents a compelling opportunity as a higher-education provider that makes obtaining a degree more affordable and cost-worthy for students. ASPU has seen consistent enrollment growth, with total enrollment at just under 10,000 students.” His $10 price target suggests an impressive 50% upside potential for the stock. (To watch Grondahl's track record, click here)Aspen sells for a bargain $6.66, a price that is especially attractive when the upside potential is taken into account. The average price target, $9.75, indicates room for 46% growth to the upside in this stock. The Strong Buy analyst consensus is based on 4 Buy ratings set in the last two months. (See Aspen stock analysis on TipRanks)Sarepta Therapeutics (SRPT)Based in Cambridge, Massachusetts, Sarepta is a mid-cap ($7 billion) biotech company focusing on treatments for genetic disorders. The company’s first approved product, Exondys 51, is a treatment for Duchenne muscular dystrophy, and is approved for patients with a confirmed mutation in the DMD gene. Sarepta has 16 additional projects in the pipeline, mostly targeting forms of muscular dystrophy, and is a collaborator on 9 others.Unfortunately, Sarepta received devastating news in August. The FDA rejected the company's NDA application for golodirsen (SRP-4053) for the treatment of boys with Duchenne muscular dystrophy (DMD) amenable to exon 53 skipping. The CRL, which is the FDA's euphemism for a rejection, outlined two main concerns: Intravenous (IV) infusion ports at risk of infections, and preclinical models of golodirsen displaying renal toxicity, observed following administration of other antisense oligonucleotides. Disappointed investors expecting the company to announce FDA approval pounded the stock all the way to a 52-week low of $72.05 in late September.However, SRPT has shown head-turning signs of life recently. Over the past five weeks, Sarepta stock has rallied about 30%, and Guggenheim analyst Whitney Ijem sees much more upside potential.Ijem gives an upbeat description of the company’s current standing in a November 1 initiation report: “We like the company's strategic positioning in DMD given its base RNA platform and leading gene therapy. Despite recent controversy on both, we expect positive progress in the next 6-12mos that should drive shares higher. Beyond DMD, the company has built an impressive pipeline of gene therapies in other neuromuscular diseases… we think current levels provide a highly favorable entry point ahead of what we expect will be a productive 2020.” Ijem’s $183 price target suggests a most impressive 94% upside to SRPT. (To watch Ijem's track record, click here)Indeed, the company’s robust pipeline, with 9 products in clinical testing and one Exondys 51 in commercial trials, shows that SRPT’s expenditures are going to a good end. Investors are willing to be patient with a biotech that has a strong research program.All in all, Sarepta has 18 buy ratings in the last three months, against a single hold – a clear sign that analysts and investors both are impressed with the company’s potential. Shares sell for $94, and the average price target of $191 gives the stock an eye-opening 101% upside. (See Sarepta's price targets and analyst ratings on TipRanks).Zix Corporation (ZIXI)In Zix, we move into the technology sector. This small tech company has a market cap of just $395 million, but a secure niche in the email security sector, providing encryption, data loss prevention, and mobile applications. Zix boasts over 80,000 customers, and bases its business on the popular – and profitable – cloud-based SaaS model. At the turn of the year, Zix made a significant acquisition when it bought AppRiver, a provider of cloud-based cyber security and productivity services.In Q3, reported at the end of October, ZIXI met the Street’s expectations with a 13 cent EPS. This was a 44% year-over-year gain. In terms of revenues, ZIXI beat the estimates by 1.16%, posting $47.83 million for the quarter. This was an impressive 168% increase from the year-ago quarter’s revenue figures. As fits a company with a healthy earnings profile, ZIXI shares are up 24% year-to-date, matching the performance of the S&P 500 index.Daniel Ives, 4-star analyst from Wedbush, initiated coverage on the stock last week, writing of the company, “Zix is a leader in the email encryption and delivery market providing security solutions to over 80,000 customers mainly focused on compliance driven industries such as Financial Services, Healthcare and Government. Email encryption accounts for almost 90% of its total revenue and today’s BYOD world presents many new security threats and challenges as we believe the company has strong differentiation from its competition [...] We believe that the Street does not currently fully appreciate the full potential of the AppRiver acquisition to drive top-line growth as well as EBITDA margin expansion.”Ives suggests that if everything goes as planned, ZIXI will be a $10 stock in the next 12 months, implying about 40% return. (To watch Ives' track record, click here)All in all, at just $7.10, ZIXI shares are another bargain for return-minded investors. The stock’s $10.33 average price target implies an excellent upside of 44%, and while the analyst consensus of Strong Buy is based on just three ratings, all three were given in the past two weeks. Clearly, this is a stock that is starting to attract attention from Wall Street’s analysts. (Get TipRanks' free stock analysis report on ZIXI)

  • Business Wire

    Zix Sets November 2019 Financial Conference Schedule

    Zix Corporation , a leading provider of cloud email security solutions, is scheduled to participate at the following financial conferences during November 2019:

  • Zix (ZIXI) Q3 Earnings Meet Estimates
    Zacks

    Zix (ZIXI) Q3 Earnings Meet Estimates

    Zix (ZIXI) delivered earnings and revenue surprises of 0.00% and 1.16%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Business Wire

    Zix Reports Third Quarter 2019 Financial Results

    Enhanced Cross-Selling Efforts Drive Another Quarter of 15% Organic Revenue Growth, Expanding Adjusted EBITDA Margins, and 18% Organic Annual Recurring Revenue Growth to $200

  • ACCESSWIRE

    Zix Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / October 31, 2019 / Zix Corp. (NASDAQ: ZIXI ) will be discussing their earnings results in their 2019 Third Quarter Earnings to be held on October 31, 2019 at 8:00 AM Eastern ...

  • Hedge Funds Are Selling Zix Corporation (ZIXI)
    Insider Monkey

    Hedge Funds Are Selling Zix Corporation (ZIXI)

    Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge funds’ stock picking abilities to illustrate. The Standard and Poor’s 500 Index returned approximately 20% in 2019 (through September 30th). Conversely, hedge […]

  • ZIXI vs. PFPT: Which Stock Should Value Investors Buy Now?
    Zacks

    ZIXI vs. PFPT: Which Stock Should Value Investors Buy Now?

    ZIXI vs. PFPT: Which Stock Is the Better Value Option?

  • Zix (ZIXI) to Report Q3 Earnings: What's in the Offing?
    Zacks

    Zix (ZIXI) to Report Q3 Earnings: What's in the Offing?

    High retention rate, customer wins and acquisitions are likely to have aided Zix's (ZIXI) third-quarter earnings.

  • Zix (ZIXI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
    Zacks

    Zix (ZIXI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    Zix (ZIXI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Business Wire

    Zix Moves Third Quarter 2019 Conference Call Forward to October 31 at 8:00 AM ET

    Zix Corporation , , a leading provider of cloud email security solutions, has moved up its third quarter 2019 financial results conference call and webcast to Thursday, October 31, 2019, at 8:00 a.m.

  • ZIXI vs. PFPT: Which Stock Is the Better Value Option?
    Zacks

    ZIXI vs. PFPT: Which Stock Is the Better Value Option?

    ZIXI vs. PFPT: Which Stock Is the Better Value Option?

  • Zix (ZIXI) Upgraded to Buy: Here's What You Should Know
    Zacks

    Zix (ZIXI) Upgraded to Buy: Here's What You Should Know

    Zix (ZIXI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).

  • Business Wire

    Zix to Announce Third Quarter 2019 Results on October 31

    Zix Corporation , , a leading provider of cloud email security solutions, will host a conference call and webcast to discuss the company’s financial results for the third quarter 2019 on Thursday, October 31, 2019, at 5:00 p.m.

  • Bull Of The Day: Zix (ZIXI)
    Zacks

    Bull Of The Day: Zix (ZIXI)

    Bull Of The Day: Zix (ZIXI)

  • Shareholders Are Thrilled That The Zix (NASDAQ:ZIXI) Share Price Increased 119%
    Simply Wall St.

    Shareholders Are Thrilled That The Zix (NASDAQ:ZIXI) Share Price Increased 119%

    It hasn't been the best quarter for Zix Corporation (NASDAQ:ZIXI) shareholders, since the share price has fallen 23...

  • Zix (ZIXI) Moves to Strong Buy: Rationale Behind the Upgrade
    Zacks

    Zix (ZIXI) Moves to Strong Buy: Rationale Behind the Upgrade

    Zix (ZIXI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).

  • 3 Tech Stocks with High Upside for Under $15
    TipRanks

    3 Tech Stocks with High Upside for Under $15

    With Amazon (AMZN) and Google (GOOGL) vacuuming up the reputation and the hype and the sky-high stock valuations, it sometimes seems that the tech sector isn’t for the budget-minded investor. Even the more staid stocks, like Microsoft (MSFT) can have share prices well above $100. So, what do you do if you’re looking to invest in tech but are on a tight budget? Let’s take a look at three tech stocks for cost-conscious investors – all are priced under $15 per share, and show at least 40% upside potential. Cyren Ltd. (CYRN)A small cybersecurity firm based in the suburbs of Washington, DC, Cyren has developed a reputation for product excellence. The company specializes in cloud-based security as a service (SECaaS), with products for inbound and outbound spam, phishing, malware, ransomware, and botnet detection and protection.Cyren’s reputational achievements in the field are more impressive given its small size – the company is microcap, with a total market capitalization of just $82.3 million. The stock is priced accordingly, at just $1.51 per share.The analysts agree that this stock, despite its low cost and the company’s small size, is investment grade. Writing from B. Riley FBR, Dan Drawbaugh says, “Cloud-delivered cybersecurity solutions provider Cyren reported 2Q19 results on August 14 before market open. The quarter was, on the whole, about in line with our expectations: Revenue of $9.7M met our estimate and marked a quarterly record for CYRN… we are tempering our growth outlook for the company in the second half of 2019 in order to reflect a shift in product strategy within the enterprise business and gradual expansion of the threat intelligence business.” He gives CYRN shares a $3 price target, indicating a 98% upside potential. Craig-Hallum analyst Chad Bennett agrees with Drawbaugh’s assessment, also setting a $3 target for the stock.Overall, CYRN shares have a Moderate Buy from the analyst consensus, and an average price target of $3. As noted, this target gives the stock an impressive 98% upside. FireEye, Inc. (FEYE)Silicon Valley-based FireEye provides hardware and software – and their support services – to analyze IT security, defend against malware attacks, and investigate cybersecurity breaches. FireEye has counted several blue-chip companies among its clients, including Target, JP Morgan, and Sony Pictures, and it is potentially one of the industry’s fastest growing firms. The company’s recent quarterly report was not spectacular, but did meet expectations, and confirmed several top-rated analysts in their positive views of the stock.Nomura analyst Christopher Eberle was impressed enough to initiate coverage of FEYE with a Buy rating, writing, “We see strong signs emerging of underlying recurring revenue growth, which may be the catalyst to drive overall revenue growth into the low double digits, after several years of "stagnant" mid-single-digit growth. Further, the foundation has been laid for FireEye's Helix platform, which should drive greater adoption.” Eberle’s $16 price target suggests an 18% upside for the shares.5-star analyst Jonathan Ruykhaver, from Baird, focused on FireEye’s improved billing situation when he wrote, “…billings growth accelerated to 13% supported by platform, cloud subscription and managed services which grew billings 27% Y/Y. We think end-of-life related churn is largely behind the company, and like the risk/reward going forward.” He did not put a price target on the shares, but did rate FEYE as a Buy.At $13.52, FireEye has the highest share price of the stocks in this list. The average price target, $19, suggests an upside potential of 40%. The Moderate Buy consensus rating comes from 8 buys and 4 holds given in the past three months. Zix Corporation (ZIXI) Even though much of our digital communication is handled through messenger apps, email remains important. It’s a better format for long-form messages, a more convenient format for less urgent communications, and better able to handle large document attachments. Email is here to stay, and so we need to keep it safe. That’s what Zix does. Zix’s products provide email encryption and data loss prevention. Customers have included the US Treasury and various Blue Cross Blue Shield organizations.Zix’s solid niche impressed Cowen analyst Nick Yako enough to initiate his coverage of the stock with a Buy rating. The analyst said, “The company's acquisition of AppRiver in January sets it on a new growth trajectory to reach annual recurring revenue of $257M-$350M in three to five years, up significantly from $76M in 2018.” He added that the increasing prevalence of cloud computing will prove a benefit to Zix going forward. Yako’s $11 price target indicates a possible 46% upside to ZIXI.Writing more recently, Northland Securities 5-star analyst Tim Klasell reiterated his Buy rating. Klasell agrees that the AppRiver acquisition will be a revenue driver, as will Zix’s new status as an authorized reseller of MSFT’s Office 365. Klasell gives ZIXI shares a $12 price target.Like the other stocks in this list, ZIXI has a Moderate Buy rating from the analyst consensus. Shares sell for only $7.50, and the $12 average price target gives them a 60% upside potential.Visit TipRanks’ Trending Stocks tool, and find out which stocks are hot today.

  • Does Zix Corporation (NASDAQ:ZIXI) Have A High Beta?
    Simply Wall St.

    Does Zix Corporation (NASDAQ:ZIXI) Have A High Beta?

    If you're interested in Zix Corporation (NASDAQ:ZIXI), then you might want to consider its beta (a measure of share...

  • GlobeNewswire

    Zix Sets September 2019 Financial Conference Schedule

    DALLAS, Aug. 20, 2019 -- Zix Corporation (Zix) (NASDAQ: ZIXI), a leader in email security, is scheduled to participate at the following financial conferences during September.